文献速递脑血管病外科

Woven EndoBridge 装置的系统综述:临床前动物模型的研究结果与临床结果比较

A systematic review of the Woven EndoBridge device-do findings in pre-clinical animal models compare to clinical results?
PubMed 文献 · Acta Neurochir (Wien) · 2023-06-08

本系统综述检索 PubMed 和 EMBASE,纳入 6 项动物研究和 17 项临床研究,评估 WEB 装置的性能。兔弹性蛋白酶动脉瘤模型是唯一用于评估 WEB 性能的临床前动物模型,动物研究未报告安全性结局,动物研究的疗效结局比临床研究更异质。

要点

  • 兔弹性蛋白酶动脉瘤模型是唯一用于评估 WEB 装置性能的临床前动物模型。
  • 动物研究从未报告安全性结局,因此无法与临床结局比较。
  • 动物研究的疗效结局比临床研究更异质,可能与动物模型在动脉瘤诱导和尺寸方面的外部效度有限有关。

核心结论

  • 兔弹性蛋白酶动脉瘤模型是唯一用于评估 WEB 装置性能的临床前动物模型。
  • 动物研究未评估安全性结局,因此无法与临床结局比较。
  • 动物研究的疗效结局比临床研究更异质。
  • 未来研究应聚焦于改进方法学和报告,以便对 WEB 装置的性能得出准确结论。

研究设计与样本

  • 本研究为系统综述,由 ZonMw 资助(项目编号 114024133)。
  • 在 PubMed 和 EMBASE(通过 Ovid 界面)进行了全面检索。
  • 排除标准为:非原创全长研究论文、非体内动物研究或人体研究、无 WEB 植入、人体研究为非前瞻性研究。
  • 采用 SYRCLE 偏倚风险工具评估动物研究,采用纽卡斯尔-渥太华队列研究质量评估量表评估临床研究。
  • 进行了叙述性综合。

主要发现

  • 共纳入 6 项动物研究和 17 项临床研究。
  • 兔弹性蛋白酶动脉瘤模型是唯一用于评估 WEB 装置性能的动物模型。
  • 动物研究从未报告安全性结局。
  • 动物研究的疗效结局比临床研究更异质,可能归因于动物模型在动脉瘤诱导和尺寸方面的外部效度有限。
  • 动物研究和临床研究均以单臂研究为主,且存在多种类型的偏倚风险不明确。

局限性

  • 动物研究和临床研究均以单臂研究为主,且存在多种类型的偏倚风险不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Woven Endobridge (WEB) is designed to treat intracranial wide-neck bifurcation aneurysms, preventing subarachnoid hemorrhage. The translational value of animal models used for WEB device testing is unknown. With this systematic review, we aim to identify the existing animal models used in testing the WEB device and compare the efficacy and safety outcomes to those of prospective clinical studies. METHODS: This study was funded by ZonMw: project number 114024133. A comprehensive search was performed in PubMed and in EMBASE via the Ovid interface. The following exclusion criteria were used: 1) not an original full-length research paper, 2) not an in vivo animal study or a human study, 3) no WEB implantation, 4) if in humans: not a prospective study. The SYRCLE risk of bias tool (animal studies) and the Newcastle-Ottawa quality assessment scale for cohort studies (clinical studies) were used to assess risks of bias. A narrative synthesis was performed. RESULTS: Six animal studies and 17 clinical studies met the inclusion criteria. The rabbit elastase aneurysm model was the only animal model used to assess WEB device performance. Safety outcomes were never reported in animal studies. Efficacy outcomes were more heterogeneous in animal studies than in clinical studies, which could be due to limited external validity of the animal models in terms of aneurysm induction and dimensions. Both animal and clinical studies were predominantly single-arm studies, and were at unclear risk of several types of bias. CONCLUSIONS: The rabbit elastase aneurysm model was the only pre-clinical animal model used to assess WEB device performance. Safety outcomes were not evaluated in animal studies and could therefore not be compared to clinical outcomes. Efficacy outcomes were more heterogeneous in animal studies than in clinical studies. Future research should focus on improving methodology and reporting in order to draw accurate conclusions on the performance of the WEB device.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Aquarius R, Elbertsen D, de Vries J, et al. A systematic review of the Woven EndoBridge device-do findings in pre-clinical animal models compare to clinical results? Acta Neurochir (Wien). 2023. PMID: 37289301. doi:10.1007/s00701-023-05638-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。